The CGMP facility represents a critical first step in a new era of drug manufacturing aimed at strengthening domestic supply chain resiliency

The CGMP facility represents a critical first step in a new era of drug manufacturing aimed at strengthening domestic supply chain resiliency
Collected from qualified healthy donors that meet baseline FDA 21 CFR 1271 requirements, industry’s first In Stock GMP-compliant Cryopreserved Leukopaks significantly decrease lead time
CPC (Colder Products Company), part of Dover and a leading manufacturer of connection technologies used in biopharmaceutical processing, medical, thermal management, and industrial applications, is expanding its footprint in Minneapolis-St. Paul.
soloPURE™ provides a closed, Grade-A, aseptic environment for fill finish activities requiring positive and negative pressures, giving organizations with facility restraints or expensive closed-barrier systems a better way to handle sterile potent powders, including products previously thought to be “out of reach” in conventional barrier systems.
Avantor® to Acquire Ritter GmbH and its Affiliates; Expands Proprietary Offering for Diagnostic and Drug Discovery Workflows, Combining Ritter’s liquid handling consumables platform for clinical diagnostic testing and life sciences research with Avantor’s offerings for critical lab automation workflows and leading global customer channel
Matica Biotechnology, Inc. (Matica Bio), a contract development and manufacturing organization (CDMO) specializing in the clinical and commercial production of cell and gene therapies, ceremonially broke ground today on its new 25,000 ft2 facility which will house its GMP virus production suites, development laboratories and company offices. The new building will be located in Providence Park at 2501 Earl Rudder Freeway in College Station.
The World Nano Foundation and pandemic experts say regular use of inexpensive lateral flow rapid antigen mass testing kits is the way to beat COVID-19, its variants and future viruses.
Heska Corporation, a leading global provider of advanced veterinary diagnostic and specialty products, announced today that the Company has entered into an agreement (the “Agreement”) to acquire 100% of Lacuna Diagnostics, Inc. (“Lacuna”), a pioneer and market leader in point-of-care diagnostics digital cytology technology and telemedicine services.
At a time when a clean and safe air environment is of paramount importance for school systems and businesses, certified HEPA AirBox Air Purifier Peak Series-S has been scientifically proven by independent lab testing company Microchem Laboratory to filter 99.99% of MS2 Bacteriophage, a SARS-Cov-2 (COVID-19) representative virus, and three other common pathogens in just 25 minutes, achieving a 4 log reduction of particulates.
The Prime Minister will launch the government’s new capital investment fund, the Medicines and Diagnostic Manufacturing Transformation Fund, while visiting North Wales later today. This will open up investment opportunities for medicines manufacturers in England, Scotland and Wales – improving our domestic medicine supply chains and creating thousands of highly skilled jobs in the process.
Purolite Corporation is expanding its manufacturing capabilities to address and fulfill the increasing global demand for its pharmaceutical and life science products. The new facility will include two new cleanrooms to manufacture active pharmaceutical ingredients (APIs) and excipients and an agarose manufacturing facility equipped with proprietary jetting technology for the capture and purification of (mAbs) monoclonal antibodies sold under the Praesto® brand.
SteriPack Group rapidly deploys equipment, expertise and facilities to meet critical need for sterile swabs, diagnostic products and personal protective equipment across their global manufacturing network.